Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Preliminary Safety and Efficacy of Luspatercept Initiated at Maximum Approved Dose in Patients with Transfusion Dependent Anemia Due to Very Low, Low and Intermediate Risk MDS with Ring Sideroblasts: First Results of the Lusplus Trial

Blood (2024) 144 (Supplement 1): 3207.

https://doi.org/10.1182/blood-2024-208432

Published: 2024

Journal Articles

SHERLOCK unmasks fusion-driven leukemias

Nicolas Bonadies

Blood (2024) 144 (12): 1241–1243.

https://doi.org/10.1182/blood.2024025943

Published: 2024

Journal Articles

Multiomics Profiling Reveals Higher RNA Isoform Diversity and Potential Oncospecific Protein Isoform Targets in HSPCs of MDS and MDS/MPN Patients

Nicolas Bonadies, Vladislav Grigorjev, Naomi Porret, Keith Harshman, Linda L Grob, Tata Nageswara Rao, Lina Al Tai, Rosanna Rubin, Helen Broughton, Sandra Goetze, Nora C Toussaint, Stefan Balabanov

Blood (2023) 142 (Supplement 1): 4592.

https://doi.org/10.1182/blood-2023-178092

Published: 2023

Journal Articles

Efficacy of Primary Prophylaxis in Patients with MDS or AML Treated with Non-Intensive Agents: Systematic Review with Meta-Analysis

Ioannis Chanias, Pascal Knecht, Nicolas Bonadies

Blood (2023) 142 (Supplement 1): 6491.

https://doi.org/10.1182/blood-2023-178379

Published: 2023

Journal Articles

Azacitidine Treatment in MDS: A Systematic Literature Review and Meta-Analysis Comparing the Efficacy of Real World Data with Randomized Controlled Trials

Livia Rupp, Andre Moser, Nicolas Bonadies, Michael Daskalakis

Blood (2023) 142 (Supplement 1): 6486.

https://doi.org/10.1182/blood-2023-188855

Published: 2023

Journal Articles

Biological Role of Extracellular Vesicles in Myeloid Neoplasms: A Systematic Review of the Current Literature

Ioannis Chanias, Leonie Schmidt, Manfred Heller, Nicolas Bonadies

Blood (2023) 142 (Supplement 1): 5676.

https://doi.org/10.1182/blood-2023-178261

Published: 2023

Journal Articles

Ribonuclease Inhibitor 1 (RNH1) Regulates Myeloid Lineage Choice through Cyclin-Dependent Kinase 1

Nicola Daniele Andina, Mayuresh Anant Sarangdhar, Aubry Tardivel, Camille Ansermet, Giuseppe Bombaci, Mahmoud Hallal, Vijay Kumar Chennupati, Yara Banz, Manfred Heller, Anne Angelillo-Scherrer, Nicolas Bonadies, Ramanjaneyulu Allam

Blood (2022) 140 (Supplement 1): 5726–5727.

https://doi.org/10.1182/blood-2022-168720

Published: 2022

Journal Articles

Characterization of Bypassing Kinases Inferred By Phosphoproteomics in a Midostaurin Resistant Myeloid Cell Line Model

Mahmoud Hallal, BSc, MSc, Sophie Braga-Lagache, MSc, Jovana Jankovic, Rémy Bruggmann, PhD, Ramanjaneyulu Allam, PhD MSc, BSc, Mario P. Tschan, PhD, Cédric Simillion, PhD, Manfred Heller, PhD, Nicolas Bonadies, MD

Blood (2019) 134 (Supplement_1): 2079.

https://doi.org/10.1182/blood-2019-122337

Published: 2019

Journal Articles

I-Care for MDS: Development of Guidelines-Based Indicators for Appropriate Care in Adult Patients with Myelodysplastic Syndromes

Blood (2019) 134 (Supplement_1): 4752.

https://doi.org/10.1182/blood-2019-122285

Published: 2019

Journal Articles

Effects of the Therapeutic Armamentarium on Survival and Time to Next Treatment in CMML Subtypes: An International Analysis of 950 Cases Coordinated By the AGMT Study Group

Lisa Pleyer, Michael Leisch, MD, Alexandra Kourakli, MD PhD, Eric Padron, MD, Jaroslaw P. Maciejewski, MD PhD, Blanca Xicoy, MD MSc, Jennifer Kaivers, MD, Johanna Ungerstedt, MD PhD, Sonja Heibl, MD, Peristera Patiou, MD, Anthony M. Hunter, MD, Elvira Mora, MD, Klaus Geissler, MD, Maria Dimou, MD PhD, María-José Jimenez, MD, David Kiesl, MD, Nora-Athina Viniou, MD PhD, Bhumika J. Patel, MD, Montserrat Arnan Sangerman, Peter Valent, MD, Christoforos Roubakis, MD, Teresa Bernal del Castillo, MD PhD, Athanasios Galanopoulos, MD PhD, Marisa Calabuig, MD, Nicolas Bonadies, MD, Antonio Medina de Almeida, MD PhD, Jaroslav Cermak, MD PhD, Andres Jerez, Julia Montoro, MD, Albert Cortés, Alejandro Avendaño Pita, MD, Bernardo López Andrade, MD, Eva Hellstrom Lindberg, MD PhD, Ulrich Germing, MD, Mikkael A. Sekeres, MD MS, Alan F. List, MD, Argiris Symeonidis, MD PhD, Guillermo F. Sanz, MD PhD, Richard Greil, MD

Blood (2019) 134 (Supplement_1): 844.

https://doi.org/10.1182/blood-2019-123941

Published: 2019

Journal Articles

Combined Retro- and Prospective Analysis of Adherence to Guidelines and Patient-Tailored Therapeutic Recommendations in Patients with Myelodysplastic Syndromes (MDS) at a Tertiary Care Centre

Annika Kasprzak, Kathrin Nachtkamp, MD, Mustafa Kondakci, MD, Thomas Schroeder, MD, Guido Kobbe, MD, Andrea Kündgen, MD, Jennifer Kaivers, MD, Christina Rautenberg, MD, Rainer Haas, MD, Norbert Gattermann, MD, Nicolas Bonadies, MD, Ulrich Germing, MD

Blood (2019) 134 (Supplement_1): 4250.

https://doi.org/10.1182/blood-2019-124512

Published: 2019

Journal Articles

Improvement of Relative Survival in Elderly Patients with Acute Myeloid Leukemia Emerging from Population-Based Cancer Registries in Switzerland from 2001-2013

Annatina Schnegg-Kaufmann, MD, Anita Feller, Helen Boldomero, Alicia Rovó, MD, Markus G Manz, MD, Michael Gregor, MD, Anna Efthymiou, Mario Bargetzi, MD, Urs Hess, MD, Olivier Spertini, MD, Yves Chalandon, MD PhD, Jakob R. Passweg, MDMS, Georg Stuessi, MD, Volker Arndt, MDMPH, Nicolas Bonadies, MD

Blood (2017) 130 (Supplement 1): 863.

https://doi.org/10.1182/blood.V130.Suppl_1.863.863

Published: 2017

Journal Articles

Characterization of Kinase Activity By Phosphoproteomics in Myeloid Cell Lines for Identification of Driving Oncogenic Pathways

Mahmoud Hallal, Manfred Heller, PhD, Rémy Bruggmann, PhD, Ramanjaneyulu Allam, PhD MSc, BSc, Raphael Jeancourt, PhD, Elisabeth Oppliger Leibundgut, PharmD, Cédric Simillion, PhD, Nicolas Bonadies, MD

Blood (2017) 130 (Supplement 1): 2515.

https://doi.org/10.1182/blood.V130.Suppl_1.2515.2515

Published: 2017

Journal Articles

Trends of Classification, Incidence, Mortality, and Survival of MDS Patients in Switzerland Between 2001 and 2012

Nicolas Bonadies, MD, Anita Feller, Alicia Rovo, MD, Axel Ruefer, MD, Sabine Blum, MD, Bernhard Gerber, MD, Georg Stuessi, MD, Rudolf A. Benz, MD, Nathan Cantoni, MD, Andreas Holbro, MD, Schmidt Adrian, MD, Thomas Lehmann, MD, Matthias Wilk, MD, Volker Arndt, MD MPH

Blood (2016) 128 (22): 5539.

https://doi.org/10.1182/blood.V128.22.5539.5539

Published: 2016

Journal Articles

Expression of the leukemia oncogene Lmo2 is controlled by an array of tissue-specific elements dispersed over 100 kb and bound by Tal1/Lmo2, Ets, and Gata factors

Josette-Renée Landry, Nicolas Bonadies, Sarah Kinston, Kathy Knezevic, Nicola K. Wilson, S. Helen Oram, Mary Janes, Sandie Piltz, Michelle Hammett, Jacinta Carter, Tina Hamilton, Ian J. Donaldson, Georges Lacaud, Jonathan Frampton, George Follows, Valerie Kouskoff, Berthold Göttgens

Blood (2009) 113 (23): 5783–5792.

https://doi.org/10.1182/blood-2008-11-187757

Published: 2009

Includes: Supplemental data

Journal Articles

The transcriptional program controlled by the stem cell leukemia gene Scl/Tal1 during early embryonic hematopoietic development

Nicola K. Wilson, Diego Miranda-Saavedra, Sarah Kinston, Nicolas Bonadies, Samuel D. Foster, Fernando Calero-Nieto, Mark A. Dawson, Ian J. Donaldson, Stephanie Dumon, Jonathan Frampton, Rekin's Janky, Xiao-Hong Sun, Sarah A. Teichmann, Andrew J. Bannister, Berthold Göttgens

Blood (2009) 113 (22): 5456–5465.

https://doi.org/10.1182/blood-2009-01-200048

Published: 2009

Includes: Supplemental data

NARROW

Preliminary Safety and Efficacy of Luspatercept Initiated at Maximum Approved Dose in Patients with Transfusion Dependent Anemia Due to Very Low, Low and Intermediate Risk MDS with Ring Sideroblasts: First Results of the Lusplus Trial

SHERLOCK unmasks fusion-driven leukemias

Multiomics Profiling Reveals Higher RNA Isoform Diversity and Potential Oncospecific Protein Isoform Targets in HSPCs of MDS and MDS/MPN Patients

Efficacy of Primary Prophylaxis in Patients with MDS or AML Treated with Non-Intensive Agents: Systematic Review with Meta-Analysis

Azacitidine Treatment in MDS: A Systematic Literature Review and Meta-Analysis Comparing the Efficacy of Real World Data with Randomized Controlled Trials

Biological Role of Extracellular Vesicles in Myeloid Neoplasms: A Systematic Review of the Current Literature

Ribonuclease Inhibitor 1 (RNH1) Regulates Myeloid Lineage Choice through Cyclin-Dependent Kinase 1

Characterization of Bypassing Kinases Inferred By Phosphoproteomics in a Midostaurin Resistant Myeloid Cell Line Model

I-Care for MDS: Development of Guidelines-Based Indicators for Appropriate Care in Adult Patients with Myelodysplastic Syndromes

Effects of the Therapeutic Armamentarium on Survival and Time to Next Treatment in CMML Subtypes: An International Analysis of 950 Cases Coordinated By the AGMT Study Group

Combined Retro- and Prospective Analysis of Adherence to Guidelines and Patient-Tailored Therapeutic Recommendations in Patients with Myelodysplastic Syndromes (MDS) at a Tertiary Care Centre

Improvement of Relative Survival in Elderly Patients with Acute Myeloid Leukemia Emerging from Population-Based Cancer Registries in Switzerland from 2001-2013

Characterization of Kinase Activity By Phosphoproteomics in Myeloid Cell Lines for Identification of Driving Oncogenic Pathways

Trends of Classification, Incidence, Mortality, and Survival of MDS Patients in Switzerland Between 2001 and 2012

Expression of the leukemia oncogene Lmo2 is controlled by an array of tissue-specific elements dispersed over 100 kb and bound by Tal1/Lmo2, Ets, and Gata factors

The transcriptional program controlled by the stem cell leukemia gene Scl/Tal1 during early embryonic hematopoietic development

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only